On May 12th, Ardelyx Inc (NASDAQ:ARDX) shares plummeted 39%, quite a stark drop. The cause: a disappointing read-out of the first of two …
Yesterday, drug maker Kite Pharma Inc (NASDAQ:KITE) disclosed the death of a patient who was treated with KTE-C19, the company’s CAR-T blood cancer drug, …
In a research report issued yesterday, BTIG analyst Richard Greenfield initiates coverage with a Hold on Snap Inc. (NYSE:SNAP) without suggesting a price target, assessing …
BTIG analyst Dane Leone weighs in on Ocular Therapeutix Inc (NASDAQ:OCUL), following the news that CFO Bradford Smith will step down from his position as …
LendingClub Corp (NYSE:LC) shares took a dive in after-hours trading Tuesday, after the peer-to-peer lending platform swung to a fourth-quarter loss and operating …
In a research report released Thursday, BTIG analyst Dane Leone reiterated a Buy rating on shares of Celgene Corporation (NASDAQ:CELG) with a price …
This morning, Ocular Therapeutix Inc (NASDAQ:OCUL) announced the resubmission of a New Drug Application (NDA) to the FDA for Dextenza, a drug-device combination for …
BTIG analyst Tim Chiang weighed in today on Synergy Pharmaceuticals Inc (NASDAQ:SGYP), after the drug maker reported the achievement of a milestone few biotechnology companies reach—FDA …
BTIG analyst Mark Palmer is stepping left and downgrading Bancorp Inc (NASDAQ:TBBK) from a Buy to a Neutral rating after the financial holding firm’s shares achieved …
As Synergy Pharmaceuticals Inc (NASDAQ:SGYP) prepares to release top-line results from two pivotal Phase 3 IBS-C trials before 2016 ends, BTIG analyst Tim …
